China ( The cow news digital ) Beijing — Scientists in China have developed genetically engineered mosquitoes capable of delivering vaccines to wild bats, aiming to provide immunity against deadly viruses such as rabies and Nipah. The innovative approach could prevent these pathogens from spilling over from animals to humans, potentially averting future outbreaks.
Bats have long been recognized as reservoirs for various zoonotic viruses, including rabies and Nipah virus, which can occasionally jump to humans in events known as “spillover.” Vaccinating these bats in their natural habitats has remained a significant challenge due to their large populations and mobility.
Researchers at the Wuhan Institute of Virology have devised a method using vaccine-laden mosquitoes combined with saline nets to transmit immunity to bats without capturing or directly handling them. This strategy, termed “environmental vaccination,” is considered both safer and more effective than traditional methods.
According to the scientists, vaccinated mosquitoes bite bats and deliver a small dose of the vaccine, prompting the bats’ immune systems to develop protection against the targeted viruses. The technique could significantly reduce the risk of pathogens spreading to humans, particularly in regions where bats live in large, dense colonies.
“This method allows us to immunize bats in the wild on a large scale, without causing stress or harm to the animals,” said the lead researcher at the institute. “It’s a preventive measure that addresses public health concerns before viruses can spill over to humans.”
read more
The approach has broader implications for controlling emerging infectious diseases. By targeting animal reservoirs, scientists hope to reduce the likelihood of future pandemics and safeguard both human and animal health. Environmental vaccination also provides a model for combating other zoonotic threats in wildlife populations, potentially offering a blueprint for global disease prevention strategies.
While the technique is still in experimental stages, early trials indicate that mosquitoes can successfully transfer the vaccine to bats, resulting in measurable immunity. Researchers plan further studies to optimize delivery, safety, and effectiveness before potential field deployment.
This breakthrough highlights the intersection of biotechnology, wildlife management, and public health, demonstrating creative approaches to combating diseases at their source.
